Drug repurposing to target SARS-CoV-2 brain infection

OrganoTherapeutics received support from the Luxembourgish Ministry of Economy for the project “Drug repurposing to target SARS-CoV-2 brain infection”. In this project we use our human brain organoid technology to investigate how the SARS-CoV-2 virus, causing COVID19, is infecting cells in the human brain and whether specific therapeutics for this infection of brain cells can be developed. This project is conducted in collaboration with the Luxembourg Institute of Health (LIH) and Deep Bio Insights
We are proud that this gives us a chance to contribute to the fight against the current healthy crisis.

Leave a Reply

Your email address will not be published. Required fields are marked *